ExodusPoint Capital Management »

Prelude Therapeutics shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $83k 16k 5.33
2024-09-30 $1.9M 922k 2.07
2021-12-31 $259k 21k 12.47
2020-09-30 $214k 7.1k 30.11

More positions owned by ExodusPoint Capital Management

Amazon Put Option (AMZN)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Apple Put Option (AAPL)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
NVIDIA Corporation Put Option (NVDA)
Topbuild
Penumbra (PEN)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Shopify Cl A Sub Vtg Shs Call Option (SHOP)
Advanced Micro Devices Call Option (AMD)
Warner Bros Discovery Com Ser A Call Option (WBD)
Intel Corporation Put Option (INTC)
Select Sector Spdr Tr St Str Finl Etf (XLF)
Microsoft Corporation (MSFT)

View all positions for ExodusPoint Capital Management

Top funds holding Prelude Therapeutics

OrbiMed Advisors
Baker Bros. Advisors
RA Capital Management
Soleus Capital Management
Kynam Capital Management
Vanguard Capital Management
BlackRock
Sphera Funds Management
Two Sigma Investments
ADAR1 Capital Management
Millennium Management
Geode Capital Management
Adage Capital Partners GP
Acadian Asset Management
Morgan Stanley

View all funds holding Prelude Therapeutics